BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20092724)

  • 41. Epirubicin, cisplatin, and protracted venous infusion of 5-fluorouracil for esophagogastric adenocarcinoma: response, toxicity, quality of life, and survival.
    Bamias A; Hill ME; Cunningham D; Norman AR; Ahmed FY; Webb A; Watson M; Hill AS; Nicolson MC; O'Brien ME; Evans TC; Nicolson V
    Cancer; 1996 May; 77(10):1978-85. PubMed ID: 8640659
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Neoadjuvant chemotherapy in high-grade advanced gastric cancer with protracted infusional 5-fluorouracil and consecutive low-dose cisplatin].
    Kondo K; Murase M; Yokoyama Y; Kato J; Hibi K; Kasai Y; Akiyama S; Ito K; Takagi H
    Gan To Kagaku Ryoho; 1996 Sep; 23(10):1299-303. PubMed ID: 8831742
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Retrospective analysis of 56 patients with advanced gastric cancer treated with combination of intravenous and intra-arterial intensified neoadjuvant chemotherapy.
    Li GL; Liu K; Bao Y; Cao JM; Xu J; Wang XL; Wu B; Li JS
    Chin Med J (Engl); 2012 Mar; 125(5):780-5. PubMed ID: 22490574
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thymidylate synthase and dihydropyrimidine dehydrogenase are related to histological effects of 5-fluorouracil and cisplatin neoadjuvant chemotherapy for primary gastric cancer patients.
    Fukuda H; Takiguchi N; Koda K; Oda K; Seike K; Miyazaki M
    Cancer Invest; 2006; 24(3):235-41. PubMed ID: 16809149
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Induction chemotherapy with S-1 plus cisplatin followed by surgery for treatment of gastric cancer with peritoneal dissemination.
    Okabe H; Ueda S; Obama K; Hosogi H; Sakai Y
    Ann Surg Oncol; 2009 Dec; 16(12):3227-36. PubMed ID: 19777180
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Value of normalization window of tumor vasculature in neoadjuvant chemotherapy for patients with unresectable gastric cancer].
    Zheng YB; Cao FY; Liu KJ; Gan HF; He XB; Tong SL
    Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Jan; 15(1):55-8. PubMed ID: 22287353
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pathologic complete response after FOLFOX7 in a locally advanced rectal cancer.
    Li J; Rose MG; Perkal MF; Chao HH
    J Clin Gastroenterol; 2012 Jan; 46(1):87-8. PubMed ID: 22157222
    [No Abstract]   [Full Text] [Related]  

  • 48. Comparison of five tumor regression grading systems for gastric adenocarcinoma after neoadjuvant chemotherapy: a retrospective study of 192 cases from National Cancer Center in China.
    Zhu Y; Sun Y; Hu S; Jiang Y; Yue J; Xue X; Yang L; Xue L
    BMC Gastroenterol; 2017 Mar; 17(1):41. PubMed ID: 28292272
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Clinical study of the predictors to neoadjuvant chemotherapy in patients with advanced gastric cancer].
    Qu JJ; Shi YR; Hao FY
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar; 16(3):276-80. PubMed ID: 23536352
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of neoadjuvant chemotherapy with PELF-protocoll versus surgery alone in the treatment of advanced gastric carcinoma.
    Ruf C; Thomusch O; Goos M; Makowiec F; Illerhaus G; Ruf G
    BMC Surg; 2014 Jan; 14():5. PubMed ID: 24461063
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [A case report of advanced rectal cancer showing a pathological complete response by neo-adjuvant FOLFOX chemotherapy].
    Murata A; Inoue T; Maeda K; Noda E; Nagahara H; Kubo N; Tanaka H; Muguruma K; Yamada N; Ohira M; Hirakawa K
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2623-5. PubMed ID: 21224659
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic significance of free peritoneal tumor cells in the peritoneal cavity before and after neoadjuvant chemotherapy in patients with gastric carcinoma undergoing potentially curative resection.
    Lorenzen S; Panzram B; Rosenberg R; Nekarda H; Becker K; Schenk U; Höfler H; Siewert JR; Jäger D; Ott K
    Ann Surg Oncol; 2010 Oct; 17(10):2733-9. PubMed ID: 20490698
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Efficacy of neoadjuvant chemotherpy in patients with locally advanced gastric cancer].
    Wang Y; Liu TS; Zhuang RY; Cui YH; Wang ZM; Yu YY; Hou J; Sun YH; Shen KT; Shen ZB
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Feb; 16(2):166-9. PubMed ID: 23446480
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Complete clinical and pathological response to mFOLFOX6 neoadjuvant chemotherapy in a case of advanced rectal cancer].
    Mori K; Kikunaga H; Morisue A; Fujita K; Ishikawa K; Sakuragawa T; Kumai K; Miura H; Mikami S
    Gan To Kagaku Ryoho; 2012 Apr; 39(4):679-82. PubMed ID: 22504702
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of locally advanced gastric cancer with the XELOX program of neoadjuvantchemotherapy combined with laparoscopic surgery: the experience in China.
    Zheng CH; Lu J; Huang CM; Li P; Xie JW; Wang JB; Lin JX
    Hepatogastroenterology; 2014 Oct; 61(135):1876-82. PubMed ID: 25713882
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of docetaxel combined with oxaliplatin and fluorouracil against stage III/IV gastric cancer.
    Yu YJ; Sun WJ; Lu MD; Wang FH; Qi DS; Zhang Y; Li PH; Huang H; You T; Zheng ZQ
    World J Gastroenterol; 2014 Dec; 20(48):18413-9. PubMed ID: 25561810
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of Borrmann type IV gastric cancer with a neoadjuvant chemotherapy combination of docetaxel, cisplatin and 5-fluorouracil/leucovorin.
    Sun XC; Lin J; Ju AH
    J Int Med Res; 2011; 39(6):2096-102. PubMed ID: 22289524
    [TBL] [Abstract][Full Text] [Related]  

  • 58. PCF Chemotherapy Combined with Surgical Treatment of Late Gastric Cancer.
    Du Y; Cheng X; Yu P; Yang L; Wang B; Huang L; Dong R; Xu Z; Zhou Y
    Hepatogastroenterology; 2014 Jun; 61(132):1159-64. PubMed ID: 26158181
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [A patient with advanced gastric cancer who obtained downstaging and underwent radical surgery by neoadjuvant chemotherapy].
    Kawahara M; Nashimoto A; Yabusaki H; Takii Y; Tsuchiya Y; Tanaka O; Sasaki J
    Gan To Kagaku Ryoho; 2000 Apr; 27(4):609-12. PubMed ID: 10791005
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Complications after radical gastrectomy following FOLFOX7 neoadjuvant chemotherapy for gastric cancer.
    Li ZY; Shan F; Zhang LH; Bu ZD; Wu AW; Wu XJ; Zong XL; Wu Q; Ren H; Ji JF
    World J Surg Oncol; 2011 Sep; 9():110. PubMed ID: 21942969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.